Interview with Dr Peter A Kaufman
Dr Peter A Kaufman, discussed the promising activity demonstrated by motesanib in a small phase 1b trial of women with locally recurrent, unresectable, or metastatic breast cancer.
Dr Peter A Kaufman, Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, discussed the promising activity demonstrated by motesanib in a small phase 1b trial of women with locally recurrent, unresectable, or metastatic breast cancer.
MP3 DOWNLOAD: PETER_KAUFMAN.mp3
(Right click to download podcast)
Related Videos
Related Content
